Podcast
Questions and Answers
A researcher is investigating the dynamics of B cell activation and differentiation during a secondary immune response. Which of the following scenarios would most accurately reflect the expected kinetics and characteristics of antibody production?
A researcher is investigating the dynamics of B cell activation and differentiation during a secondary immune response. Which of the following scenarios would most accurately reflect the expected kinetics and characteristics of antibody production?
- A rapid and amplified production of IgG antibodies, accompanied by affinity maturation, with a relatively short duration due to apoptosis of effector cells. (correct)
- A delayed but potent production of IgD antibodies, characterized by low-affinity binding and limited opsonization capabilities, gradually transitioning into IgE.
- A prolonged lag phase characterized by somatic hypermutation, followed by a gradual increase in IgM production and eventual class switching to IgG, IgA, or IgE.
- An immediate and robust production of IgM antibodies, sustained over several weeks, with minimal class switching due to limited T cell help.
A patient with a genetic defect exhibits impaired IgA secretion in mucosal linings. Given this deficiency, which of the following immunological challenges would this patient most likely encounter?
A patient with a genetic defect exhibits impaired IgA secretion in mucosal linings. Given this deficiency, which of the following immunological challenges would this patient most likely encounter?
- Heightened vulnerability to helminthic infestations due to the absence of IgE-mediated eosinophil degranulation.
- Systemic autoimmune reactions due to increased complement activation by circulating immune complexes.
- Increased susceptibility to intracellular bacterial infections such as _Listeria monocytogenes_.
- Elevated risk of infection by enteric and respiratory pathogens that colonize mucosal surfaces. (correct)
A novel therapeutic intervention aims to enhance ADCC activity against tumor cells. Which of the following strategies would most effectively augment this process?
A novel therapeutic intervention aims to enhance ADCC activity against tumor cells. Which of the following strategies would most effectively augment this process?
- Inhibition of Fc receptors on NK cells, preventing antibody binding and subsequent degranulation.
- Engineering bispecific antibodies that simultaneously bind tumor-associated antigens and FcγRIIIa (CD16) on NK cells. (correct)
- Enhancement of MHC class I expression on tumor cells to facilitate T cell-mediated cytotoxicity.
- Administration of high-dose corticosteroids to suppress the inflammatory response and prevent bystander damage.
In the context of T cell activation, what is the most precise description of the functional consequence of disrupting the interaction between B7 molecules on antigen-presenting cells (APCs) and CD28 on T cells?
In the context of T cell activation, what is the most precise description of the functional consequence of disrupting the interaction between B7 molecules on antigen-presenting cells (APCs) and CD28 on T cells?
A research team is investigating the mechanisms of CD8+ T cell-mediated cytotoxicity. Which of the following scenarios would most effectively impair the ability of cytotoxic T lymphocytes (CTLs) to induce apoptosis in target cells?
A research team is investigating the mechanisms of CD8+ T cell-mediated cytotoxicity. Which of the following scenarios would most effectively impair the ability of cytotoxic T lymphocytes (CTLs) to induce apoptosis in target cells?
Consider a scenario where a patient receives a bone marrow transplant from an HLA-mismatched donor. Despite immunosuppressive therapy, the patient develops severe graft-versus-host disease (GVHD). Which of the following immunological mechanisms is most likely driving the pathogenesis of GVHD in this context?
Consider a scenario where a patient receives a bone marrow transplant from an HLA-mismatched donor. Despite immunosuppressive therapy, the patient develops severe graft-versus-host disease (GVHD). Which of the following immunological mechanisms is most likely driving the pathogenesis of GVHD in this context?
A researcher is designing an experiment to assess the impact of varying cytokine environments on the differentiation of CD4+ T helper cells. Under which specific cytokine milieu would naïve CD4+ T cells most efficiently differentiate into Th1 cells?
A researcher is designing an experiment to assess the impact of varying cytokine environments on the differentiation of CD4+ T helper cells. Under which specific cytokine milieu would naïve CD4+ T cells most efficiently differentiate into Th1 cells?
A novel mutation in MHC class II molecules results in a significantly reduced ability to present antigens to CD4+ T cells. Which of the following immunological consequences would most likely arise from this mutation?
A novel mutation in MHC class II molecules results in a significantly reduced ability to present antigens to CD4+ T cells. Which of the following immunological consequences would most likely arise from this mutation?
Which of the following scenarios most accurately describes the functional role of the invariant chain (Ii) in MHC class II antigen processing and presentation?
Which of the following scenarios most accurately describes the functional role of the invariant chain (Ii) in MHC class II antigen processing and presentation?
A patient presents with a rare genetic defect resulting in the complete absence of β2-microglobulin. Which of the following immunological abnormalities would most likely be observed in this individual?
A patient presents with a rare genetic defect resulting in the complete absence of β2-microglobulin. Which of the following immunological abnormalities would most likely be observed in this individual?
A novel drug targets the interaction between the T cell receptor (TCR) and MHC molecules. Which of the following mechanisms would most effectively disrupt this interaction?
A novel drug targets the interaction between the T cell receptor (TCR) and MHC molecules. Which of the following mechanisms would most effectively disrupt this interaction?
Consider a scenario where a patient undergoes a hematopoietic stem cell transplantation (HSCT) but develops delayed immune reconstitution, particularly in T cell numbers. Which of the following strategies would most effectively enhance T cell recovery post-transplant?
Consider a scenario where a patient undergoes a hematopoietic stem cell transplantation (HSCT) but develops delayed immune reconstitution, particularly in T cell numbers. Which of the following strategies would most effectively enhance T cell recovery post-transplant?
A research team is investigating the role of non-classical MHC molecules in immune regulation. Which of the following functions is most accurately associated with MHC-E?
A research team is investigating the role of non-classical MHC molecules in immune regulation. Which of the following functions is most accurately associated with MHC-E?
A novel immunotherapeutic approach aims to enhance the presentation of tumor-associated antigens (TAAs) on MHC class I molecules. Which of the following strategies would most effectively augment this process?
A novel immunotherapeutic approach aims to enhance the presentation of tumor-associated antigens (TAAs) on MHC class I molecules. Which of the following strategies would most effectively augment this process?
Consider a scenario where a patient lacks the ability to undergo somatic hypermutation in B cells. Which of the following immunological consequences would most likely result from this deficiency?
Consider a scenario where a patient lacks the ability to undergo somatic hypermutation in B cells. Which of the following immunological consequences would most likely result from this deficiency?
A researcher is investigating the role of autophagy in antigen presentation. Which of the following processes would most likely be facilitated by autophagy in the context of MHC class II presentation?
A researcher is investigating the role of autophagy in antigen presentation. Which of the following processes would most likely be facilitated by autophagy in the context of MHC class II presentation?
A patient presents with a genetic defect that impairs the expression of the co-stimulatory molecule CD86 on antigen-presenting cells (APCs). Which of the following outcomes is most likely?
A patient presents with a genetic defect that impairs the expression of the co-stimulatory molecule CD86 on antigen-presenting cells (APCs). Which of the following outcomes is most likely?
A researcher is studying the role of regulatory T cells (Tregs) in maintaining immune homeostasis. Which of the following mechanisms is most likely employed by Tregs to suppress the activity of effector T cells?
A researcher is studying the role of regulatory T cells (Tregs) in maintaining immune homeostasis. Which of the following mechanisms is most likely employed by Tregs to suppress the activity of effector T cells?
A novel therapeutic strategy involves the use of blocking antibodies against specific cytokines to modulate adaptive immunity. Which of the following cytokine-antibody interactions would be most effective in suppressing Th17-mediated inflammation?
A novel therapeutic strategy involves the use of blocking antibodies against specific cytokines to modulate adaptive immunity. Which of the following cytokine-antibody interactions would be most effective in suppressing Th17-mediated inflammation?
A patient with a rare immunodeficiency lacks functional TAP proteins. Which of the following immunological impairments is most likely to result from this deficiency?
A patient with a rare immunodeficiency lacks functional TAP proteins. Which of the following immunological impairments is most likely to result from this deficiency?
Flashcards
Humoral Immunity
Humoral Immunity
Immunity mediated by secreted antibodies, defending against extracellular microbes and toxins.
Cell-Mediated Immunity
Cell-Mediated Immunity
Adaptive immunity mediated by T cells, eradicating intracellular microbes.
Neutralization (Antibodies)
Neutralization (Antibodies)
Antibodies block microbe binding to cells, preventing infection.
Opsonization
Opsonization
Signup and view all the flashcards
ADCC
ADCC
Signup and view all the flashcards
Complement Activation (by Antibodies)
Complement Activation (by Antibodies)
Signup and view all the flashcards
Mucosal/Neonatal Immunity (Antibodies)
Mucosal/Neonatal Immunity (Antibodies)
Signup and view all the flashcards
Primary Immune Response
Primary Immune Response
Signup and view all the flashcards
Secondary Immune Response
Secondary Immune Response
Signup and view all the flashcards
CD4+ T cells' role
CD4+ T cells' role
Signup and view all the flashcards
Th1 function
Th1 function
Signup and view all the flashcards
Th2 function
Th2 function
Signup and view all the flashcards
CD8+ T cells' role
CD8+ T cells' role
Signup and view all the flashcards
T cell Activation: Signal 1
T cell Activation: Signal 1
Signup and view all the flashcards
T cell Activation: Signal 2
T cell Activation: Signal 2
Signup and view all the flashcards
CD8+ CTL Killing Process
CD8+ CTL Killing Process
Signup and view all the flashcards
Perforin
Perforin
Signup and view all the flashcards
Granzymes Function
Granzymes Function
Signup and view all the flashcards
MHC Definition
MHC Definition
Signup and view all the flashcards
MHC Class I
MHC Class I
Signup and view all the flashcards
MHC Class II
MHC Class II
Signup and view all the flashcards
Study Notes
- The module covers foundations of immunology, specifically adaptive immunity and the major histocompatibility complex (MHC).
Adaptive Immunity Overview
- Adaptive immunity includes humoral and cell-mediated immunity.
Humoral Immunity
- Humoral immunity is mediated by secreted antibodies.
- It defends against extracellular microbes and microbial toxins.
Functions of Antibody Isotypes
- Neutralization: Antibodies block microbe binding to cells, inhibiting infection and spread, and prevent toxins from binding to cellular receptors.
- Opsonization: IgG antibodies coat microbes, promoting phagocytosis by binding to Fc receptors on neutrophils and macrophages.
- Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC): IgG binds infected cells via Fab regions, and Fc regions bind Fc receptors on NK cells, activating them to kill the cells. IgE binds helminthic parasites via Fab regions, and Fc regions bind Fc receptors on eosinophils, causing degranulation and parasite death.
- Complement Activation: IgG and IgM activate the complement system.
- Mucosal Immunity: IgA in mucosal secretions (GIT and RT) neutralizes microbes and toxins by blocking their entry.
- Neonatal Immunity: Maternal IgG antibodies are transported across the placenta, and antibodies in ingested milk protect newborns.
Primary Immune Response
- Upon first exposure to an antigen, there is a lag of about ten days before a specific antibody is detectable.
- The primary antibody produced is IgM.
- Antibody levels decline after a short time.
Secondary Immune Response
- Re-exposure to the same antigen results in a rapid antibody appearance and greater amount.
- The main antibody class is IgG.
- Antibodies remain detectable for months or years.
- Simultaneous exposure to a new antigen leads to a primary response for that antigen.
- The immune system possesses immunologic memory for antigens.
- During the primary response, some B lymphocytes become long-lived memory cells.
- Class switching from IgM to IgG is required for the secondary response.
Cell-Mediated Immunity
- Cell-mediated immunity eradicates intracellular microbes.
- Consists of activating naive T cells to proliferate and differentiate into effector cells, including CD4+ T helper cells and CD8+ cytolytic cells (CTLs), which eliminates intracellular microbes
Types of Cell-Mediated Immunity
- CD4+ T cells differentiate into two effector cells based on cytokine production: IL-12 leads to Th1, and IL-4 leads to Th2.
- Th1 secretes IFN-γ, which activates phagocytes to kill microbes.
- Th2 secretes IL-4 and IL-5 stimulating eosinophil and mast cell degranulation in allergy and helminthic infection.
CD8+ T Cells
- CD8+ T cells kill any cell containing intracellular microbes or microbial proteins through direct cell cytotoxicity, eliminating the reservoir of infection.
T Cell Activation
- T cells are activated by two signals.
- Signal 1: Peptide + MHC on APCs is recognized by TCR-CD3.
- Signal 2: Interaction of B7 molecule on APCs with CD28 on T cells provides a co-stimulatory signal.
- Absence of the second signal leads to T-cells to enter anergy (unresponsiveness).
Steps of CD8+ CTL Killing
- CTLs recognize class I MHC + peptides on the surface of infected target cells.
- Tight adhesions (“conjugates”) are formed with these cells.
- CTLs are activated by IL-2 & IFN-γ to release their granule contents, leading to granule exocytosis.
- Granule contents include perforin, which forms pores in the target cell membrane.
- Granzymes enter cells through the pores and induce apoptosis by activating capases
- CTL detaches to kill other cells
- Target cell death occurs.
Major Histocompatibility Complex (MHC)
- MHC is a group of genes on the short arm of chromosome 6, and these produce MHC molecules.
- MHC molecules are present on cell surfaces.
- MHC is responsible for displaying protein antigens to T cells; it is also called human leucocytic Ag = HLA.
Classification of Genes (MHC)
- Class I MHC genes include HLA-A, HLA-B, and HLA-C and are involved in antigen presentation to Tc cells.
- Class II MHC genes include HLA-D region genes (HLA-DR, HLA-DP, and HLA-DQ) promoting antigen presentation to Th cells.
- Class III MHC genes lie between class I & II and produce some complement components and TNF-α but do not produce MHC.
Structure and Distribution of MHC Molecules
- MHC molecules are membrane proteins expressed on cells.
- Both class I & II molecules consist of an extracellular part, a transmembrane part, and a cytoplasmic part to anchor the molecule to the cell.
Class I MHC Molecules
- Two polypeptide chains form Class I MHC molecules.
- The alpha chain has three domains (α1, α2, α3), attached to β2 microglobulin outside MHC.
- α1 and α2 domains create a cleft or groove that binds to peptides.
- It presents antigens to CD8+ T cells.
- Class I molecules are expressed on all nucleated cells.
Class II MHC Molecules
- Class II MHC molecules are made of two polypeptide chains, an alpha chain (α1 & α2) and a beta chain (β1 & β2).
- The α1 and β1 domains form the peptide-binding cleft.
- Class II is expressed on APCs only.
Additional Information
- B7 molecules on APCs bind with CD28 on T cells during T cell activation.
- Class I MHC presents antigen to Th (CD4), NK, Tc (CD8), monocytes and macrophges.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.